The DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.
Epstein–Barr virus latent genes
Open accessAbstract
Latent Epstein–Barr virus (EBV) infection has a substantial role in causing many human disorders. The persistence of these viral genomes in all malignant cells, yet with the expression of limited latent genes, is consistent with the notion that EBV latent genes are important for malignant cell growth. While the EBV-encoded nuclear antigen-1 (EBNA-1) and latent membrane protein-2A (LMP-2A) are critical, the EBNA-leader proteins, EBNA-2, EBNA-3A, EBNA-3C and LMP-1, are individually essential for in vitro transformation of primary B cells to lymphoblastoid cell lines. EBV-encoded RNAs and EBNA-3Bs are dispensable. In this review, the roles of EBV latent genes are summarized. The latent form of Epstein-Barr virus (EBV) relies on a small arsenal of genes to manipulate host cell genes and promote cancerous growth. Many people unknowingly harbor EBV, which remains latent in immune and epithelial cells after initial infection. The latent virus is harmless if it remains dormant but if it becomes reactivated it can contribute to a variety of different cancers and immune disorders. Myung-Soo Kang at the Sungkyunkwan University School of Medicine in Korea and Elliott Kieff of Harvard Medical School in the USA review current knowledge regarding the specific genes that become active in the latent virus. Their analysis reveals diverse parallel mechanisms by which EBV removes the blocks that inhibit cell division while at the same time thwarting the controlled ‘self-destruct’ mechanisms that act as a critical safeguard against cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–235 of 235
Scoy, S. V., Watakabe, I., Krainer, A. R., & Hearing, J. C. (2000) · Virology · doi:10.1006/viro.2000.0508 · Cited by 53
Multiple functions are mediated by the miRNAs of Epstein-Barr virus
Kuzembayeva, M., Hayes, M., & Sugden, B. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.04.003 · Cited by 52
Mouse models of human cancer as tools in drug development
Holland, E. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.004 · Cited by 52
Epstein–Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines
Zhao, B., Mar, J. C., Maruo, S., Lee, S. W., Gewurz, B. E., Johannsen, E., Holton, K. M., Rubio, R., Takada, K., Quackenbush, J. F., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017419108 · Cited by 52
Self-citationWalling, D. M., Ray, A. J., Nichols, J. E., Flaitz, C. M., & Nichols, C. M. (2007) · Journal of Virology · doi:10.1128/jvi.02754-06 · Cited by 52
Banerjee, S., Lu, J. L., Cai, Q., Sun, Z., Jha, H. C., & Robertson, E. S. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004304 · Cited by 51
Jha, H. C., Lu, J. L., Saha, A., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02379-13 · Cited by 49
Viral dsRNA Inhibitors Prevent Self-association and Autophosphorylation of PKR
McKenna, S. A., Lindhout, D. A., Shimoike, T., Aitken, C. E., & Puglisi, J. D. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.028 · Cited by 49
Yang, J., Deng, X., Deng, L., Gu, H., Fan, W., & Cao, Y. (2004) · PubMed · Cited by 48
Kim, A. L., Maher, M., Hayman, J. B., Ozer, J. S., Zerby, D., Yates, J. L., & Lieberman, P. M. (1997) · Virology · doi:10.1006/viro.1997.8874 · Cited by 48
Malik-Soni, N., & Frappier, L. (2012) · Journal of Virology · doi:10.1128/jvi.00194-12 · Cited by 47
Portal, D., Zhao, B., Calderwood, M. A., Sommermann, T. G., Johannsen, E., & Kieff, E. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104991108 · Cited by 46
Self-citationToczyski, D. P., & Steitz, J. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.703 · Cited by 46
Repeat Arrays in Cellular DNA Related to the Epstein-Barr Virus IR3 Repeat
Heller, M., Flemington, E. K., Kieff, E. D., & Deininger, P. L. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.3.457 · Cited by 45
Self-citationPortal, D., Rosendorff, A., & Kieff, E. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609320103 · Cited by 45
Self-citationElia, A., Vyas, J. J., Laing, K. G., & Clemens, M. J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04099.x · Cited by 44
Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis
Bieging-Rolett, K. T., Amick, A. C., & Longnecker, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907994106 · Cited by 41
Nasimuzzaman, M., Kuroda, M., Dohno, S., Yamamoto, T., Iwatsuki, K., Matsuzaki, S., Rashel, M., Kumita, W., Mizuguchi, H., Hayakawa, T., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.017 · Cited by 41
Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo
Anderson, L. J., & Longnecker, R. (2008) · Blood · doi:10.1182/blood-2008-06-160937 · Cited by 40
Epstein-Barr Virus Essential Antigen EBNA3C Attenuates H2AX Expression
Jha, H. C., Mahadesh Prasad, A. J., Saha, A., Banerjee, S., Lu, J. L., & Robertson, E. S. (2014) · Journal of Virology · doi:10.1128/jvi.03568-13 · Cited by 38
Lee, S. W., Sakakibara, S., Maruo, S., Zhao, B., Calderwood, M. A., Holthaus, A. M., Lai, C.-Y., Takada, K., Kieff, E. D., & Johannsen, E. (2009) · Journal of Virology · doi:10.1128/jvi.01403-09 · Cited by 37
Self-citationIwakiri, D., Minamitani, T., & Samanta, M. (2013) · Journal of Virology · doi:10.1128/jvi.01089-13 · Cited by 37
Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis.
Sugden, B., & Warren, N. (1988) · PubMed · Cited by 35
Fu, C., Liu, C., Lindvall, C. J., Xu, D., & Ernberg, I. T. (2004) · International Journal of Cancer · doi:10.1002/ijc.20594 · Cited by 34
Fogg, M. H., Kaur, A., Cho, Y.-G., & Wang, F. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12681-12691.2005 · Cited by 34
Liu, C., Chen, Y., Min, Y.-L., Zhao, B., Cheng, C., Kang, M.-S., Chiu, S.-J., Kieff, E. D., & Peng, C. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003084 · Cited by 32
Self-citationAvoiding Proteasomal Processing: The Case of EBNA1
Dantuma, N. P., Sharipo, A., & Masucci, M. G. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59421-2_2 · Cited by 31
Bazot, Q., Deschamps, T., Tafforeau, L., Siouda, M., Leblanc, P., Harth-Hertle, M. L., Rabourdin‐Combe, C., Lotteau, V., Kempkes, B., Tommasino, M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku697 · Cited by 31
Rovedo, M. A., & Longnecker, R. (2008) · Journal of Virology · doi:10.1128/jvi.00843-08 · Cited by 31
Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization
Kim, S. Y., Song, K.-A., Kieff, E. D., & Kang, M.-S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.095 · Cited by 29
Self-citationMalik-Soni, N., & Frappier, L. (2013) · Journal of Virology · doi:10.1128/jvi.02521-13 · Cited by 29
Epstein–Barr virus latent membrane protein 2A and autoimmunity
Swanson-Mungerson, M. A., & Longnecker, R. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.03.002 · Cited by 28
Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses
Saha, A., & Robertson, E. S. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.007 · Cited by 22
Komano, J. A., & Takada, K. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1561-1564.2001 · Cited by 21
Replacement of the Epstein-Barr Virus Plasmid with the EBER Plasmid in Burkitt's Lymphoma Cells
Maruo, S., Nanbo, A., & Takada, K. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9977-9982.2001 · Cited by 19
Cited by
Epstein–Barr virus infection and nasopharyngeal carcinoma
Tsao, S. W., Tsang, C. M., & Lo, K. W. (2017) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0270 · Cited by 606
Epstein-Barr virus and multiple sclerosis
Robinson, W. H., & Steinman, L. (2022) · Science · doi:10.1126/science.abm7930 · Cited by 310
Serquiña, A. K. P., Tagawa, T., Oh, D., Mahesh, G., & Ziegelbauer, J. M. (2021) · mBio · doi:10.1128/mbio.02907-21 · Cited by 24
Metadata
- Authors
- Kang, M.-S., & Kieff, E.
- Venue
- Experimental & Molecular Medicine
- Published
- 2015-01-23
- Volume
- 47
- Issue
- 1
- Pages
- e131-e131
- ISSN
- 1226-3613 (ISSN-L)
- 2092-6413
- OpenAlex
- W2154255170
- Cited by
- 361
- References
- 235
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.